FGEN $38.80 1.71 (4.22%)FibroGen Inc
Market Cap 4 Billion
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
EPS 1.34 P/E Ratio 0.00
Previous Thu, Aug 8, 2019
Latest Thu, Nov 14, 2019 (In 26 days)
Pay Date --
May 10, 2019
Feb 28, 2019
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.